Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D; community with critical information on the tools, technologies, and trends that drive the biotech industry.
Issue link: http://gen.epubxp.com/i/716943
Genetic Engineering & Biotechnology News | GENengnews.com | SEPTEMBER 1, 2016 | 41 Illumina named Philip W. Schiller to its board of directors...Retrophin elected Roy D. Baynes, M.D., Ph.D., to its board of directors...Decibel Therapeutics wel- comed Steven H. Holtzman as president and CEO...Ranya Dajani is the new vp, corporate development of Advaxis... Second Genome hired Glenn Nedwin, Ph.D., as CEO...Biostage added Harout DerSimonian, Ph.D., as CSO...Thomas A. Shea joined Albireo as CFO...Bio- Marin named Willard Dere, M.D., and Kathryn E. Falberg to its board...Bicycle Therapeutics appointed Stephen Hoff- man as board chairman...John Demaree is now vp of oncology marketing, Amer- icas for Astellas. Protagen elected Bernhard Kirsch- baum as chairman and Oliver Schacht as member of its board...Boston Phar- maceuticals welcomed Ian Sanderson as CFO...Fouad Namouni, M.D., joined Bristol-Myers Squibb as oncology de- velopment head...Theranos hired Dave Wurtz as vp of regulatory and quality and Daniel Guggenheim chief compli- ance officer...Jeffrey Bartlett, Ph.D., is now CSO of Calimmune...ProterixBio named Fernando Martinez, M.D., to its scientific advisory board...Andrew E. Mulberg, M.D., is the new vp of regula- tory strategy at Amicus Therapeutics. Promethera Biosciences appointed Massimo Pinzani, M.D., Ph.D., as chair- man and Anil Dhawan, M.D., Sanjeev Gupta, Michael Ott, M.D., Andreas Nuessler, Ph.D., and Patrice Cani, Ph.D., as members of its scientific and medical advisory board...Annai Systems added James Levine as CEO...HalioDx named Jerome Galon, Ph.D., Dominique Bellet, M.D., Ph.D., Carlo Bifulco, M.D., Alex- ander M.M. Eggermont, M.D., Ph.D., Stanley R. Hamilton, M.D., Ignacio Me- lero, M.D., Ph.D., Frederique Penault- Llorca, M.D., Ph.D., and Josep Taberne- ro, M.D., Ph.D., to its scientific advisory board...Arquer Diagnostics welcomed Louise Flintoft as product manager. Astellas added Joseph Devaney as vp, government affairs and policy in the Americas...Lisa Nolan, Ph.D., is now CBO of Rexahn Pharmaceuticals...Rich- ard D. Katz, M.D., is the new CFO of Ar- gos Therapeutics...PureTech welcomed Feng Zhang, Ph.D., to its scientific advi- sory board, Jeff Stevens as vp of growth strategy & operations, and Meghan Fitzgerald, DrPH, Philip J. Larsen, M.D., Ph.D., and Atul Pande, M.D., as senior advisors...William Bauta, Ph.D., joined bioAffinity Technologies as svp for research and development...uniQure welcomed Jonathan Garen as CBO. Renee Selman is now CCO of Agile Therapeutics...NeuroDerm hired Tami Yardeni as COO and Eran Shor as vp de- vices...Flexion Therapeutics added Mark Fraga as vp of marketing, Scott Kelley, M.D., as vp of medical affairs, and Dan Thornton as vp of market access...Jena Roberts is the new vp, business develop- ment at Novolyze...Cidara Therapeutics welcomed Neil Abdollahian as CBO and Matt Onaitis as CFO and and general counsel...Ravi Nalliah is now CEO of TrakCel...Valneva appointed Ralf Clem- ens, M.D., Ph.D., and Lisa Shaw-Marot- to to its supervisory board. Lucia Septien, M.D., joined DBV Technologies as CMO...Cellceutix add- ed Arthur P. Bertolino, M.D., Ph.D., as president and CMO...Aviragen Thera- peutics hired Jonas Niaura as vp, corpo- rate development and strategy....Rock- well Medical named Robin L. Smith, M.D., to its board of directors...Kamada elected Naveh Tov, M.D., Ph.D., as vp, clinical development and medical direc- tor for pulmonary diseases. PEOPLE Send your People Announcements to people@GENengnews.com Reprints Karen Ballen 914-740-2194 reprints@GENengnews.com GEN offers reprints of individual articles — in print- ed or electronic form — to increase awareness of your product or company. Order today! Subscribe Clinical OMICs extends GEN's comprehensive coverage to the clinic by focusing on the application of revolutionary molecular technologies in medical practice. Topics covered include personalized and precision medicine, next-gen sequencing, bioinformatics, reimbursement, and bioethics. To see past issues, recent news, and subscribe, go to: clinicalomics.com GEN'S NEW ePUB Molecular Diagnostics in Personalized Medicine ACEA Biosciences . . . . . . . . . . . . . . 16 Active Motif . . . . . . . . . . . . . . . . . . . . 19 Advanced Analytical . . . . . . . . . . . 34 BD . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 Bio-Rad Laboratories . . . . . . . . . 4,44 BugLab . . . . . . . . . . . . . . . . . . . . . . . . 28 Cayman Chemical . . . . . . . . . . . . . . 32 Cell Signaling . . . . . . . . . . . . . . . . . . 11 CISBIO . . . . . . . . . . . . . . . . . . . . . . . . . 15 Clinical OMICs . . . . . . . . . . . . . . . . . 41 Drummond Scientific . . . . . . . . . . 29 ESACT . . . . . . . . . . . . . . . . . . . . . . . . . 31 Eurogentec S.A. . . . . . . . . . . . . . . . . 18 Finesse . . . . . . . . . . . . . . . . . . . . . . . . 27 Fluid-Screen . . . . . . . . . . . . . . . . . . . 39 GE Life Sciences . . . . . . . . . . . . . . . . . 9 GEN/Agilent Technologies . . . . . . 21 Levitronix . . . . . . . . . . . . . . . . . . . . . . 25 Merck . . . . . . . . . . . . . . . . . . . 33,35,37 MilliporeSigma. . . . . . . . . . . 33,35,37 Molecular Devices . . . . . . . . . . . . . 17 MP Biomedicals . . . . . . . . . . . . . . . . . 2 OriGene . . . . . . . . . . . . . . . . Cover Tip Pall Life Sciences . . . . . . . . . . . . . . . . 3 PerkinElmer . . . . . . . . . . . . . . . . . . . . 13 RayBiotech . . . . . . . . . . . . . . . . . . . . 30 Sigma-Aldrich . . . . . . . . . . . . . . . . . 43 Sonntek . . . . . . . . . . . . . . . . . . . . . . . 41 Waters . . . . . . . . . . . . . . . . . . . . . . . . . . 7 A D V E R T I S E R I N D E X Classified P R O F I L E Editas Medicine named Akshay Vaishnaw, M.D., Ph.D., to its board of direc- tors. Currently, he is evp of research and develop- ment and CMO at Alnylam Pharma- ceuticals, and he is on the board of directors at Visterra. P R O F I L E TARA Biosystems elected Robert Langer, Ph.D., to its board of direc- tors. Currently, he is the David H. Koch Institute Professor at MIT. In the past, Dr. Langer was chairman of the U.S. Food and Drug Administra- tion's Science Board and was elected to the National Academy of Medicine. Warp Drive Bio appointed Rachel K. King to its board of directors. Cur- rently, she is CDO of GlycoMimetics. Before that, Ms. King was at New Enterprise Asso- ciates, Novartis, Genetic Therapy, and ALZA. She brings over 25 years of biotech- nology leader- ship experience. P R O F I L E David A. Ricks is the new president and CEO of Eli Lilly effective January 1, 2017 and chair- man of its board on May 31, 2017. Currently, Mr. Ricks is svp and president of Lilly Bio-Medicines. He has held numerous posi- tions at Eli Lilly. P R O F I L E SONNTEK,INC.